Usual dose of sublingual fentanyl in the treatment of breakthrough pain in patients with lung cancer under conditions of clinical practice
Current
Archives
Pre Publicaciones
Authors
Editorial aspects to consider
Recommendations for manuscript preparation
Instructions for authors
About the Journal
Información general y alcance
Equipo editorial
Mission and vision
Publication frequency
Open access and funding
Digital preservation
Indexing
Standardised abbreviated title
Languages
Social media
Editorial process and peer review
Ethics, integrity and best practices
Contacto
Contact
Register
Login
Change the language. The current language is:
English
Spanish
Register
Login
Change the language. The current language is:
English
Spanish
Vol. 24 No. 3 (2017)
,
Letter to the Editor
Vol. 24 No. 3 (2017)
Usual dose of sublingual fentanyl in the treatment of breakthrough pain in patients with lung cancer under conditions of clinical practice
Letter to the Editor
Published 2017-05-01
Pilar Resano Barrio
+
−
Pilar Resano Barrio
Hospital de Guadalajara
PDF (Spanish)
PDF (Spanish)
Downloads
Download data is not yet available.
×
Username
*
Required
Password
*
Required
Forgot your password?
Keep me logged in
Login
No account?
Register here
